COMMUNIQUÉS West-GlobeNewswire
-
Precision Neuroscience™ Wins 2026 Webby Award; Earns Back-to-Back Fast Company World Changing Ideas Honor
17/06/2026 -
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
17/06/2026 -
BPGbio Presents Latest Clinical and Translational Findings Supporting BPM31510 in Primary CoQ10 Deficiency at Mito Med 2026
17/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17/06/2026 -
Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series
17/06/2026 -
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
17/06/2026 -
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
17/06/2026 -
MedX Holdings Accelerates Growth: Expanding Lazydaze Franchise Footprint, Unveiling Major Product Innovations, and Strengthening Brand Infrastructure
17/06/2026 -
Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data
17/06/2026 -
Christian Wichert appointed Chief Executive Officer to lead next phase of growth
17/06/2026 -
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17/06/2026 -
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
17/06/2026 -
Glass House Brands Announces its Deconsolidation of its Dual-Use Business and its Application for Uplisting of Shares to NYSE
17/06/2026 -
Trading in GN Store Nord shares by board members, executives and associated persons
17/06/2026 -
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
17/06/2026 -
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
17/06/2026 -
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
17/06/2026 -
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
17/06/2026 -
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
17/06/2026
Pages